These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 1388654)

  • 21. CSF-1 and its receptor in breast carcinomas and neoplasms of the female reproductive tract.
    Kacinski BM
    Mol Reprod Dev; 1997 Jan; 46(1):71-4. PubMed ID: 8981366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Large-scale production of human tumorcytotoxic macrophages grown from blood monocytes of cancer patients.
    Brugger W; Scheibenbogen C; Krause S; Andreesen R
    Cancer Detect Prev; 1991; 15(5):407-12. PubMed ID: 1751952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of tumour necrosis factor receptor-expressing macrophages by interleukin-10 and macrophage colony-stimulating factor in rheumatoid arthritis.
    Takasugi K; Yamamura M; Iwahashi M; Otsuka F; Yamana J; Sunahori K; Kawashima M; Yamada M; Makino H
    Arthritis Res Ther; 2006; 8(4):R126. PubMed ID: 16859503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: a new approach to cancer immunotherapy.
    Andreesen R; Scheibenbogen C; Brugger W; Krause S; Meerpohl HG; Leser HG; Engler H; Löhr GW
    Cancer Res; 1990 Dec; 50(23):7450-6. PubMed ID: 1701343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pivotal Advance: PKCzeta is required for migration of macrophages.
    Guo H; Ma Y; Zhang B; Sun B; Niu R; Ying G; Zhang N
    J Leukoc Biol; 2009 Jun; 85(6):911-8. PubMed ID: 19201988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Akt2 is required for macrophage chemotaxis.
    Zhang B; Ma Y; Guo H; Sun B; Niu R; Ying G; Zhang N
    Eur J Immunol; 2009 Mar; 39(3):894-901. PubMed ID: 19197940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of macrophage chemotaxis by neoplastic and other rapidly proliferating cells in vitro.
    Normann SJ; Sorkin E
    Cancer Res; 1977 Mar; 37(3):705-11. PubMed ID: 189909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MRL/lpr and MRL+/+ macrophage DNA synthesis in the absence and the presence of colony-stimulating factor-1 and granulocyte-macrophage colony-stimulating factor.
    Hamilton JA; Chan J; Byrne RJ; Bischof RJ; Jaworowski A; Kanagasundaram V
    J Immunol; 1998 Dec; 161(12):6802-11. PubMed ID: 9862711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-associated macrophages as targets for tumor immunotherapy.
    Weigert A; Sekar D; Brüne B
    Immunotherapy; 2009 Jan; 1(1):83-95. PubMed ID: 20635976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New in vitro test systems].
    Hofstädter F; Konur A; Andreesen R; Knüchel R
    Urologe A; 1995 May; 34(3):212-4. PubMed ID: 7610515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune control of neoplasia by adoptive transfer of macrophages: potentiality for antigen presentation and gene transfer.
    Bartholeyns J; Lopez M
    Anticancer Res; 1994; 14(6B):2673-6. PubMed ID: 7872699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibroblast-secreted macrophage colony-stimulating factor is responsible for generation of biphenotypic B/macrophage cells from a subset of mouse B lymphocytes.
    Borrello MA; Phipps RP
    J Immunol; 1999 Oct; 163(7):3605-11. PubMed ID: 10490953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type I interferons inhibit the generation of tumor-associated macrophages.
    U'Ren L; Guth A; Kamstock D; Dow S
    Cancer Immunol Immunother; 2010 Apr; 59(4):587-98. PubMed ID: 19826812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathophysiology of tumor-associated macrophages.
    Yuan A; Chen JJ; Yang PC
    Adv Clin Chem; 2008; 45():199-223. PubMed ID: 18429498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macrophage colony-stimulating factor release and receptor expression in bone cells.
    Weir EC; Horowitz MC; Baron R; Centrella M; Kacinski BM; Insogna KL
    J Bone Miner Res; 1993 Dec; 8(12):1507-18. PubMed ID: 8304053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunophenotypical changes of neoplastic cells and tumor-associated macrophages in a rat dendritic cell sarcoma-derived transplantable tumor line (KB-D8).
    Kawashima M; Ide M; Nakanishi M; Kuwamura M; Kumagai D; Yamate J
    Virchows Arch; 2003 Feb; 442(2):141-50. PubMed ID: 12596065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer related inflammation: the macrophage connection.
    Sica A; Allavena P; Mantovani A
    Cancer Lett; 2008 Aug; 267(2):204-15. PubMed ID: 18448242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colon cancer cell-derived tumor necrosis factor-alpha mediates the tumor growth-promoting response in macrophages by up-regulating the colony-stimulating factor-1 pathway.
    Zins K; Abraham D; Sioud M; Aharinejad S
    Cancer Res; 2007 Feb; 67(3):1038-45. PubMed ID: 17283136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of CSF-1, c-fms, and MCP-1 in the central nervous system of rats with experimental allergic encephalomyelitis.
    Hulkower K; Brosnan CF; Aquino DA; Cammer W; Kulshrestha S; Guida MP; Rapoport DA; Berman JW
    J Immunol; 1993 Mar; 150(6):2525-33. PubMed ID: 8450228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monocyte chemotactic cytokine gene transfer modulates macrophage infiltration, growth, and susceptibility to IL-2 therapy of a murine melanoma.
    Bottazzi B; Walter S; Govoni D; Colotta F; Mantovani A
    J Immunol; 1992 Feb; 148(4):1280-5. PubMed ID: 1737940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.